Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNα Kinoid in Lupus
/
Date03 Feb 2017
PARIS, Feb. 03, 2017 (GLOBE NEWSWIRE) — Neovacs (Alternext Paris:ALNEV), a leader in active immunotherapy for the treatment of autoimmune diseases, today announced that it... Read More →
Superior Uniform Group Declares Regular Quarterly Cash Dividend
/
Date03 Feb 2017
SEMINOLE, Fla., Feb. 03, 2017 (GLOBE NEWSWIRE) — The Board of Directors of Superior Uniform Group, Inc. (NASDAQ:SGC) today declared a quarterly dividend of $0.0875... Read More →
PennTex Midstream Partners, LP Reports Fourth Quarter and Full Year 2016 Results
/
Date03 Feb 2017
HOUSTON, Feb. 03, 2017 (GLOBE NEWSWIRE) — PennTex Midstream Partners, LP (NASDAQ:PTXP) (the “Partnership”) today reported fourth quarter and full year 2016 financial and operational... Read More →
Atlassian Completes Acquisition of Trello
/
Date03 Feb 2017
SAN FRANCISCO, Feb. 03, 2017 (GLOBE NEWSWIRE) — Atlassian Corporation Plc (NASDAQ:TEAM), a leading provider of team collaboration and productivity software, today announced it has... Read More →
HealthEquity to Present at Leerink Healthcare Conference
/
Date03 Feb 2017
DRAPER, Utah, Feb. 03, 2017 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ:HQY) (“HealthEquity” or the “Company”), one of the largest HSA non-bank custodians, today announced it... Read More →
Tuesday Morning Corporation Announces Second Quarter Fiscal 2017 Results
/
Date03 Feb 2017
DALLAS, Feb. 03, 2017 (GLOBE NEWSWIRE) — Tuesday Morning Corporation (NASDAQ:TUES), a leading off-price retailer currently with 720 stores across the United States specializing in... Read More →
Årsrapport 2016 Kapitalforeningen World Wide Invest
/
Date03 Feb 2017
Resultatet for 2016 efter omkostninger blev -1,9 %. Se den samlede årsrapport i vedhæftede pdf. Spørgsmål til årets resultat kan rettes til foreningens forvalter Tiedemann... Read More →
Leap Therapeutics Presents Biomarker and Efficacy Data at the Cholangiocarcinoma Foundation 2017 Annual Meeting
/
Date03 Feb 2017
CAMBRIDGE, Mass., Feb. 03, 2017 (GLOBE NEWSWIRE) — Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, announced the presentation of biomarker... Read More →
Gencor Releases First Quarter Fiscal 2017 Results
/
Date03 Feb 2017
ORLANDO, Fla., Feb. 03, 2017 (GLOBE NEWSWIRE) — Gencor Industries, Inc. (Nasdaq:GENC) announced today net revenues increased 19% to $15.8 million for the quarter ended... Read More →
Årsrapport 2016 for Independent Invest
/
Date03 Feb 2017
Resultater for 2016 Globale aktieafdelinger: Independent Global 0,5 % Independent Generations -6,1 %* Virksomhedsobligationer: Independent Bond 4,8 % Læs Årsrapporten 2016 med beretninger i vedhæftede... Read More →